Journal of Oral Implantology — Dental implant surgery procedures can conflict with the medication needs of heart patients. A less invasive approach to dental implants offers heart patients a better surgical and postsurgical experience, and allows patients to undergo the procedure without interruption of long-term anticoagulant medication. The
Journal of Oral Implantology presents two cases in which a flapless surgical technique was used rather than conventional implant techniques. In the flapless technique, implants are drilled directly through the soft tissue into the bone. This study assessed the potential of the modified procedure to reduce bleeding, surgery time, postoperative pain, and soft tissue inflammation.
ALSO FROM THE JOURNAL OF ORAL IMPLANTOLOGY |Fluoride treatment of synthetic biomaterial assists dental bone regeneration For patients with prosthetic heart valves, deep vein thrombosis, and other heart conditions, lifelong oral anticoagulant therapy is often prescribed. Warfarin is a commonly prescribed anticoagulant that reduces the risk of thromboembolism. Whether warfarin should be discontinued before dental procedures has been a subject of debate — is the risk of thromboembolism when an anticoagulant is withdrawn a greater threat than the risk of bleeding if it is continued?
ALSO FROM THE JOURNAL OF ORAL IMPLANTOLOGY |Stronger bone for oral surgery created by introducing microcracks in the jawbone In this study, the minimally invasive flapless implant technique was used for two heart patients — a 45-year-old woman and a 58-year-old man. Both patients continued their warfarin therapy without interruption. After implant surgery, the patients were monitored for 30 minutes, and subsequent examinations took place one week, five weeks, and six months after the operation. Both patients showed good healing, minimal inflammation, and no abnormalities. No signs of bleeding were present in their follow-up exams.